arrow
R

Ruth Lynfield

Minnesota Department of Health
H指数:98
被引数:4.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Detecting Nonreportable Disease Trends Using Electronic Health Records: Human Parvovirus B19 in Minnesota, January 2019 Through September 2024

利用电子健康记录检测非报告性疾病趋势:明尼苏达州人类细小病毒B19,2019年1月至2024年9月

2026-10-110
PRE
Trends in Mortality and the Effects of the Coronavirus Disease 2019 Pandemic on Mortality Among Adult Patients With Staphylococcus aureus Bacteremia, 20 US Counties, 2005–2022

金黄色葡萄球菌败血症成人患者死亡趋势及2019冠状病毒病大流行对死亡的影响:美国20个县,2005–2022年

2026-08-210
OAAI
Prevalence and outcomes of bacterial co-detections by blood culture among children and adults hospitalized with laboratory-confirmed influenza, Influenza Hospitalization Surveillance Network, 2022-2024

实验室确诊流感住院儿童和成人中,通过血培养检测到的细菌共感染患病率及结局,流感住院监测网络,2022-2024

2026-05-200
PRE
Public reporting guidelines for outbreak data: Enabling accountability for effective outbreak response by developing standards for transparency and uniformity
2026-01-210
PRE
The epidemiology of bacterial meningitis in the United States during 2008-2023: an analysis of active, laboratory, population-based, multistate surveillance data

2008-2023年美国细菌性脑膜炎的流行病学:一项对主动、实验室、基于人群的多州监测数据的分析

2025-07-010
PRE
Trends in Incidence and Epidemiology of Methicillin-Resistant Staphylococcus aureus Bacteremia, Six Emerging Infections Program Surveillance Sites, 2005-2022

耐甲氧西林金黄色葡萄球菌菌血症的发病趋势和流行病学特征:六个新兴感染监测项目的哨点,2005-2022年

2025-06-012
PRE
Invasive Group A Streptococcal Infections in 10 US States

10个美国州侵袭性A族链球菌感染

2025-05-061
PRE
WHO defeating meningitis symposium, 3rd international symposium on Streptococcus agalactiae disease (ISSAD) in Rio de Janeiro, Brazil: State-of-the-art overview of S. agalactiae meningitis

世界卫生组织战胜脑膜炎研讨会,第三届国际无乳链球菌疾病研讨会(ISSAD)在巴西里约热内卢:无乳链球菌脑膜炎的最新综述

VACCINE
IF3.5
2025-04-011
PRE
Characteristics of nursing homes with high rates of invasive methicillin-resistant Staphylococcus aureus infections
2025-01-200
OA
An Observational Study to Determine the Prevalence of COVID-19 Among Hospitalized Patients With Multidrug-Resistant Enterobacterales Infections and Clinical Outcomes, 10 US Sites, 2020-2022
2024-12-260
OA
The Burden of All-Cause Mortality Following Influenza-Associated Hospitalizations: Influenza Hospitalization Surveillance Network, 2010-2019
2024-11-040
OA
Extrapolating Sentinel Surveillance Information to Estimate National COVID Hospital Admission Rates: A Bayesian Modeling Approach
2024-10-230
OA
Genomic Epidemiology of Extrapulmonary Nontuberculous Mycobacteria Isolates at Emerging Infections Program Sites-United States, 2019-2020
2024-10-070
OA
Carbapenem-resistant Acinetobacter baumannii complex in the United States-An epidemiological and molecular description of isolates collected through the Emerging Infections Program, 2019

美国耐碳青霉烯类鲍曼不动杆菌复合体-通过新兴感染计划收集的分离株的流行病学和分子描述,2019

2024-09-017
OAAI
Timing of Influenza Antiviral Therapy and Risk of Death in Adults Hospitalized With Influenza-Associated Pneumonia, Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012-2019
2024-08-226
OA
Infectious disease surveillance needs for the United States: lessons from Covid-19

美国的传染病监测需求: 新型冠状病毒肺炎的教训

2024-07-151
OAAI